Best adjuvant (assist) for chemotherapy | 1+1>487% | Effectively improve chemotherapy effect, treatment, immunity. Reduce side effects and recurrence. Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work | Abstract / Summary / Overview of Apoptosis.
Why do cells undergo apoptosis?
The relationship between cancer cells and apoptosis.
Where are the weaknesses and symptoms of cancer cells?
Are cancer cells aggressive?
Extraordinary Solamargine (Role, Principle, Action, Mechanism, Function, Work)
Solamargine 's major function mechanism:
Solamargine vs cancer
Best Chemotherapy Adjuvant. (1+1>478%)
Effectively improve chemotherapy effect and cure.
When cancer cells are less resistant to drugs, chemotherapy becomes more effective.
Extract : https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq
Non-Small Cell Lung Cancer Treatment General Information About Non-Small Cell Lung Cancer KEY POINTS Non-small cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung. There are several types of non-small cell lung cancer. Smoking is the major risk factor for non-small cell lung cancer. Signs of non-small cell lung cancer include a cough that doesn't go away and shortness of breath. Tests that examine the lungs are used to diagnose and stage non-small cell lung cancer. If lung cancer is suspected, a biopsy is done. Certain factors affect prognosis (chance of recovery) and treatment options. For most patients with non-small cell lung cancer, current treatments do not cure the cancer.
Abstract / Summary / Overview of Apoptosis.
Overview of apoptosis
•Programmed cell death
•Apoptosis is a form of programmed cell death, or “cellular suicide.”
•Apoptosis is different from necrosis, in which cells die due to injury.
•Apoptosis removes cells during development, eliminates potentially cancerous and virus-infected cells, and maintains balance in the body.
Why do cells undergo apoptosis? Basically, apoptosis is a general and convenient way to remove cells that should no longer be part of the organism. Some cells are abnormal and could hurt the rest of the organism if they survive, such as cells with viral infections or DNA damage. Apoptosis is part of development In many organisms, programmed cell death is a normal part of development.
The relationship between cancer cells and apoptosis Apoptosis can eliminate infected or cancerous cells.
When a cell’s DNA is damaged, it will typically detect the damage and try to repair it.
If the damage is beyond repair, the cell will normally send itself into apoptosis, ensuring that it will not pass on its damaged DNA.
When cells have DNA damage but fail to undergo apoptosis, they may be on the road to cancer.
However, “successful” cancer cells successfully evade the process of apoptosis.
This allows them to divide out of control and accumulate mutations (changes in their DNA).
Apoptosis is key to immune function
Apoptosis also plays an essential role in the development and maintenance of a healthy immune system.
Where are the weaknesses and symptoms of cancer cells? The symptoms of cancer cells are in the nucleus.
The nucleus controls the outer cytoplasm, cell composition, cell viability, etc.
DNA mutations also mutate in the nucleus.
Therefore, to treat cancer cells, we must first enter the nucleus.
Let the “regulatory cell gene” mechanism enter the nucleus to regulate
Are cancer cells aggressive? After the action of Solamargine , the aggressiveness of cancer cells is alleviated.
So after using Solamargine , many patients feel that I am half better.
Although the tumor does not disappear quickly, patients feel that the degree of aggressiveness is reduced.
Extraordinary Solamargine (Role, Principle, Action, Mechanism, Function, Work).
Solamargine 's major function mechanism:
When Solamargine enter, Solamargine activates receptors that are turned off by cancer cells, allowing cancer cells to modulate again. Solamargine modulates the anti-modulates genes of cancer cells, making cancer cells less resistant. Reduced drug resistance When cancer cells are less resistant to drugs, chemotherapy becomes more effective. Solamargine modulates the mutated genes in cancer cells and then initiates cancer cell apoptosis to achieve anti-cancer effects.
Solamargine combined with which chemotherapy drugs are more effective in treating cancer cells?
Solamargine vs cancer
Solamargine vs cancer The picture shows the death of cancer cells.
The black and black parts are cancer cell nuclei.
Even if the nucleus ruptures, the cancer cells will die.
The figure shows that cancer cells can cause death.
The figure shows that cancer cells can cause death.
The figure shows that the death of lung cancer cells is relatively slow, and it will not be obvious until eight hours later.
The figure shows that the death of liver cancer cells is very obvious, even more obvious in eight hours.
The graph shows that breast cancer cells die faster. It was obvious from the beginning that breast cancer is easy to treat, and patients with breast cancer need not worry.
Best Chemotherapy Adjuvant. (1+1>487%) Effectively improve chemotherapy effect and treatment. ANTI-CANCER Patent protection in 32 nations. A comparison study showing Solamargine vs. other therapeutic drugs with respect to lung cancer cells. A comparison study showing Solamargine vs. other chemotherapeutic drugs with respect to breast cancer cells.
SR-T100 combination therapy with effective result against breast cancer cells.
Combination Therapy | Research results for lung cancer cells. A. Chemotherapy (100μM), 16% of cancer cell apoptosis. B. Alone SM (4.8μM), 28% of cancer cell apoptosis. C. SM (4.80μM) + Chemotherapy (40μM), 66% of cancer cells apoptosis. D. SM (4.80μM) + Chemotherapy (100μM), 78% of cancer cell apoptosis. SM has a clearing effect better than Chemotherapy . The combined treatment of Solamargine and Chemotherapy significantly increased the apoptosis of lung cancer cells. SM (4.8μ M) + Chemotherapy (40μM), increased from 16% to 66% (up to 4.125 times). SM (4.8μM) + Chemotherapy (100μM), increased from 16% to 78% (up to 4.875 times). Reorganized from: BBRC. Action of Solamargine on TNFs and drug-resistant human lung cancer cells 2004.
Solamargine Q&A (English)
survival rate | cancer | Contents survival rate | cancer | Etymology and definitions survival rate | cancer | Signs and symptoms survival rate | cancer | Local symptoms survival rate | cancer | Systemic symptoms survival rate | cancer | Metastasis survival rate | cancer | Causes survival rate | cancer | Chemicals survival rate | cancer | Diet and exercise survival rate | cancer | Infection survival rate | cancer | Radiation survival rate | cancer | Heredity survival rate | cancer | Physical agents survival rate | cancer | Hormones survival rate | cancer | Autoimmune diseases survival rate | cancer | Pathophysiology survival rate | cancer | Genetics survival rate | cancer | Epigenetics survival rate | cancer | Metastasis survival rate | cancer | Metabolism survival rate | cancer | Diagnosis survival rate | cancer | Classification survival rate | cancer | Prevention survival rate | cancer | Dietary survival rate | cancer | Medication survival rate | cancer | Vaccination survival rate | cancer | Screening survival rate | cancer | Recommendations survival rate | cancer | Genetic testing survival rate | cancer | Management survival rate | cancer | Cancer survival rate | cancer | Radiation survival rate | cancer | Surgery survival rate | cancer | Palliative care survival rate | cancer | Immunotherapy survival rate | cancer | Laser therapy survival rate | cancer | Alternative medicine survival rate | cancer | Prognosis survival rate | cancer | Epidemiology survival rate | cancer | History survival rate | cancer | Society and culture survival rate | cancer | Economic effect survival rate | cancer | Workplace survival rate | cancer | Research survival rate | cancer | Pregnancy survival rate | cancer | Other animals survival rate | cancer | Notes survival rate | cancer | Further reading survival rate | cancer | External links Non-small cell lung cancer | NSCLC | survival rate | Contents Non-small cell lung cancer | NSCLC | survival rate | Etymology and definitions Non-small cell lung cancer | NSCLC | survival rate | Signs and symptoms Non-small cell lung cancer | NSCLC | survival rate | Local symptoms Non-small cell lung cancer | NSCLC | survival rate | Systemic symptoms Non-small cell lung cancer | NSCLC | survival rate | Metastasis Non-small cell lung cancer | NSCLC | survival rate | Causes Non-small cell lung cancer | NSCLC | survival rate | Chemicals Non-small cell lung cancer | NSCLC | survival rate | Diet and exercise Non-small cell lung cancer | NSCLC | survival rate | Infection Non-small cell lung cancer | NSCLC | survival rate | Radiation Non-small cell lung cancer | NSCLC | survival rate | Heredity Non-small cell lung cancer | NSCLC | survival rate | Physical agents Non-small cell lung cancer | NSCLC | survival rate | Hormones Non-small cell lung cancer | NSCLC | survival rate | Autoimmune diseases Non-small cell lung cancer | NSCLC | survival rate | Pathophysiology Non-small cell lung cancer | NSCLC | survival rate | Genetics Non-small cell lung cancer | NSCLC | survival rate | Epigenetics Non-small cell lung cancer | NSCLC | survival rate | Metastasis Non-small cell lung cancer | NSCLC | survival rate | Metabolism Non-small cell lung cancer | NSCLC | survival rate | Diagnosis Non-small cell lung cancer | NSCLC | survival rate | Classification Non-small cell lung cancer | NSCLC | survival rate | Prevention Non-small cell lung cancer | NSCLC | survival rate | Dietary Non-small cell lung cancer | NSCLC | survival rate | Medication Non-small cell lung cancer | NSCLC | survival rate | Vaccination Non-small cell lung cancer | NSCLC | survival rate | Screening Non-small cell lung cancer | NSCLC | survival rate | Recommendations Non-small cell lung cancer | NSCLC | survival rate | Genetic testing Non-small cell lung cancer | NSCLC | survival rate | Management Non-small cell lung cancer | NSCLC | survival rate | Chemotherapy Non-small cell lung cancer | NSCLC | survival rate | Radiation Non-small cell lung cancer | NSCLC | survival rate | Surgery Non-small cell lung cancer | NSCLC | survival rate | Palliative care Non-small cell lung cancer | NSCLC | survival rate | Immunotherapy Non-small cell lung cancer | NSCLC | survival rate | Laser therapy Non-small cell lung cancer | NSCLC | survival rate | Alternative medicine Non-small cell lung cancer | NSCLC | survival rate | Prognosis Non-small cell lung cancer | NSCLC | survival rate | Epidemiology Non-small cell lung cancer | NSCLC | survival rate | History Non-small cell lung cancer | NSCLC | survival rate | Society and culture Non-small cell lung cancer | NSCLC | survival rate | Economic effect Non-small cell lung cancer | NSCLC | survival rate | Workplace Non-small cell lung cancer | NSCLC | survival rate | Research Non-small cell lung cancer | NSCLC | survival rate | Pregnancy Non-small cell lung cancer | NSCLC | survival rate | Other animals Non-small cell lung cancer | NSCLC | survival rate | Notes Non-small cell lung cancer | NSCLC | survival rate | Further reading Non-small cell lung cancer | NSCLC | survival rate | External links